These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6473980)

  • 41. The treatment of chronic pulmonary hypertension by vasodilators: hope and hesitation.
    Jezek V
    Eur Heart J; 1988 Sep; 9 Suppl J():1-6. PubMed ID: 3053178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for the judicious use of placebos in PAH trials.
    White RJ; Hiremath J
    J Heart Lung Transplant; 2010 Jul; 29(7):826-7. PubMed ID: 20471863
    [No Abstract]   [Full Text] [Related]  

  • 43. [Treatment of primary pulmonary hypertension with vasodilator drugs].
    Rigau D; Agustí A
    Med Clin (Barc); 2003 Feb; 120(5):194-6. PubMed ID: 12605828
    [No Abstract]   [Full Text] [Related]  

  • 44. Pulmonary vasodilators in postoperative pulmonary hypertension.
    Kashani IA; Swensson RE
    Am Heart J; 1983 Oct; 106(4 Pt 1):778-9. PubMed ID: 6613826
    [No Abstract]   [Full Text] [Related]  

  • 45. Plexogenic pulmonary hypertension of unknown origin. What's new?
    Lockhart A; Reeves JT
    Clin Sci (Lond); 1984 Jul; 67(1):1-5. PubMed ID: 6375936
    [No Abstract]   [Full Text] [Related]  

  • 46. Long-term clinical trials in pulmonary hypertension. Long overdue.
    Theodore J; Burke CM
    Chest; 1986 Jan; 89(1):4-5. PubMed ID: 3510108
    [No Abstract]   [Full Text] [Related]  

  • 47. Hydralazine and the treatment of primary pulmonary hypertension.
    Kadowitz PJ; Hyman AL
    N Engl J Med; 1982 Jun; 306(22):1357-9. PubMed ID: 7070463
    [No Abstract]   [Full Text] [Related]  

  • 48. [Vasotropic therapy and artificial respiration for pulmonary hypertension].
    Grimminger F; Olschewski H; Seeger W
    Internist (Berl); 1999 Jul; 40(7):747-55. PubMed ID: 10429917
    [No Abstract]   [Full Text] [Related]  

  • 49. Papaverine, a vasodilator with antiviral activity.
    Koch HJ; Raschka C
    Swiss Med Wkly; 2002 Feb; 132(7-8):105; author reply 105. PubMed ID: 11971205
    [No Abstract]   [Full Text] [Related]  

  • 50. Current trends in research and clinical trials of drugs for chronic pulmonary hypertension.
    Morpurgo M; Jezek V
    Eur Heart J; 1988 Sep; 9 Suppl J():39-43. PubMed ID: 3053184
    [No Abstract]   [Full Text] [Related]  

  • 51. Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy.
    Johnson SW; Gillmeyer KR; Bolton RE; McCullough MB; Qian SX; Maron BA; Klings ES; Wiener RS
    Ann Am Thorac Soc; 2022 Jul; 19(7):1236-1239. PubMed ID: 35312466
    [No Abstract]   [Full Text] [Related]  

  • 52. Flow-mediated dilatation in human circulation: diagnostic and therapeutic aspects.
    Kelm M
    Am J Physiol Heart Circ Physiol; 2002 Jan; 282(1):H1-5. PubMed ID: 11748041
    [No Abstract]   [Full Text] [Related]  

  • 53. Identifying New Targets for Treatment of Pulmonary Hypertension.
    Trammell AW; Hart CM
    Chest; 2021 Apr; 159(4):1326-1327. PubMed ID: 34021991
    [No Abstract]   [Full Text] [Related]  

  • 54. The latest generation of troponin immunoassays: the "cholesterol" of the third millennium?
    Lippi G; Cervellin G
    J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2883-4. PubMed ID: 24794126
    [No Abstract]   [Full Text] [Related]  

  • 55. [Vasodilator agents in pulmonary hypertension].
    Farga V
    Rev Med Chil; 1987 Sep; 115(9):902-4. PubMed ID: 3506285
    [No Abstract]   [Full Text] [Related]  

  • 56. The effects of vasodilators in pulmonary hypertension: pulmonary vascular or peripheral vascular?
    Rich S
    Circ Heart Fail; 2009 Mar; 2(2):145-50. PubMed ID: 19808330
    [No Abstract]   [Full Text] [Related]  

  • 57. [Vasodilator therapy in pulmonary arterial hypertension of unknown cause (primary)].
    Lupi Herrera E
    Arch Inst Cardiol Mex; 1982; 52(3):189-90. PubMed ID: 7114962
    [No Abstract]   [Full Text] [Related]  

  • 58. [Vasodilators in "primary" pulmonary hypertension?].
    Morpurgo M
    G Ital Cardiol; 1990 Feb; 20(2):123-25. PubMed ID: 2328865
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of pulmonary hypertension with vasodilation agents].
    Tschopp JM
    Schweiz Rundsch Med Prax; 1984 Jun; 73(25):789-91. PubMed ID: 6473980
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.